PSR1 COST-EFFECTIVENESS OF CLOPIDOGREL VERSUS ASPIRIN IN THE PREVENTION OF ISCHEMIC EVENTS IN STROKE AND TIA PATIENTS- A FOUR-EUROPEAN COUNTRY ANALYSIS
Abstract
Authors
AJ Palmer S Roze G Hankey Z Hakimi J Spiesser P Carita S Gabriel